Mathilde Warcoin

623 total citations
7 papers, 270 citations indexed

About

Mathilde Warcoin is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Mathilde Warcoin has authored 7 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Mathilde Warcoin's work include Cancer Genomics and Diagnostics (3 papers), Genetic factors in colorectal cancer (3 papers) and BRCA gene mutations in cancer (3 papers). Mathilde Warcoin is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Genetic factors in colorectal cancer (3 papers) and BRCA gene mutations in cancer (3 papers). Mathilde Warcoin collaborates with scholars based in France, Morocco and Mali. Mathilde Warcoin's co-authors include Dominique Stoppa‐Lyonnet, Marc‐Henri Stern, Nadège Gruel, Anne Vincent‐Salomon, Elisabeth Turpin, Florence Coulet, Jean Feunteun, Élodie Manié, Hugues de Thé and Patrick R. Benusiglio and has published in prestigious journals such as Cancer Research, Journal of Medical Genetics and Human Mutation.

In The Last Decade

Mathilde Warcoin

7 papers receiving 260 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathilde Warcoin France 5 148 103 100 95 78 7 270
Petra Zemánková Czechia 10 149 1.0× 106 1.0× 72 0.7× 117 1.2× 97 1.2× 23 308
Tadeusz Dębniak Poland 9 111 0.8× 67 0.7× 80 0.8× 160 1.7× 69 0.9× 14 246
F. B. F. Law Hong Kong 10 228 1.5× 96 0.9× 91 0.9× 242 2.5× 127 1.6× 10 387
Monica Marabelli Italy 7 87 0.6× 57 0.6× 81 0.8× 90 0.9× 65 0.8× 17 185
Susan L. Slager United States 2 115 0.8× 52 0.5× 75 0.8× 134 1.4× 59 0.8× 3 222
Sarah S K Yue China 7 96 0.6× 177 1.7× 141 1.4× 28 0.3× 87 1.1× 7 299
Mahbubl Ahmed United Kingdom 6 128 0.9× 70 0.7× 45 0.5× 86 0.9× 73 0.9× 13 232
Munemasa Nagao Japan 7 143 1.0× 79 0.8× 37 0.4× 66 0.7× 37 0.5× 13 211
Makia J. Marafie Kuwait 11 142 1.0× 37 0.4× 50 0.5× 154 1.6× 79 1.0× 28 279
Johanna Kondelin Finland 6 144 1.0× 77 0.7× 111 1.1× 22 0.2× 72 0.9× 8 225

Countries citing papers authored by Mathilde Warcoin

Since Specialization
Citations

This map shows the geographic impact of Mathilde Warcoin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde Warcoin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde Warcoin more than expected).

Fields of papers citing papers by Mathilde Warcoin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathilde Warcoin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde Warcoin. The network helps show where Mathilde Warcoin may publish in the future.

Co-authorship network of co-authors of Mathilde Warcoin

This figure shows the co-authorship network connecting the top 25 collaborators of Mathilde Warcoin. A scholar is included among the top collaborators of Mathilde Warcoin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathilde Warcoin. Mathilde Warcoin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Beddok, Arnaud, Fabienne Lesueur, Alain Fourquet, et al.. (2024). Safety of the Breast Cancer Adjuvant Radiotherapy in Ataxia–Telangiectasia Mutated Variant Carriers. Cancers. 16(7). 1417–1417. 2 indexed citations
2.
Warcoin, Mathilde, Bruno Buecher, Lisa Golmard, et al.. (2023). First report of medulloblastoma in a patient with MUTYH ‐associated polyposis. Neuropathology and Applied Neurobiology. 49(4). e12929–e12929. 2 indexed citations
3.
Warcoin, Mathilde, et al.. (2022). Combined-modality treatment for locally advanced cervical cancer in a woman with Bloom-like syndrome: A case report and review of the literature. Strahlentherapie und Onkologie. 199(1). 102–105. 4 indexed citations
4.
Benusiglio, Patrick R., Chrystelle Colas, Erell Guillerm, et al.. (2018). Clinical implications of CTNNA1 germline mutations in asymptomatic carriers. Gastric Cancer. 22(4). 899–903. 26 indexed citations
5.
Benusiglio, Patrick R., David Malka, Étienne Rouleau, et al.. (2013). CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study. Journal of Medical Genetics. 50(7). 486–489. 106 indexed citations
6.
Manié, Élodie, Anne Vincent‐Salomon, Jacqueline Lehmann‐Che, et al.. (2009). High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors. Cancer Research. 69(2). 663–671. 112 indexed citations
7.
Warcoin, Mathilde, James Lespinasse, Gilles Despouy, et al.. (2008). Fertility defects revealing germline biallelic nonsenseNBNmutations. Human Mutation. 30(3). 424–430. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026